News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Guru Sonpavde: Potentially practice-changing highlights from 2 key Phase III clinical trials
Guru Sonpavde/adventhealth.com
Oct 21, 2024, 19:19

Guru Sonpavde: Potentially practice-changing highlights from 2 key Phase III clinical trials

Guru Sonpavde shared a post on LinkedIn:

”ESMO24 bladder cancer potentially practice-changing highlights from 2 key Phase III clinical trials on Doximity: Pleased to comment on NIAGARA (Neoadjuvant Gemcitabine-Cisplatin +/- peri-operative durvalumab for muscle-invasive bladder cancer) and AMBASSADOR (Adjuvant pembrolizumab vs observation for muscle-invasive bladder cancer) trials from AdventHealth Central Florida Cancer Institute, Orlando, Florida.”

Read further.

Adjuvant pembrolizumab AdventHealth Central Florida Cancer Institute bladder cancer cancer clinical trials Doximity Durvalumab ESMO24 Guru Sonpavde OncoDaily Oncology
Special Coverage
Blog
Mar 11, 2025, 01:37
ASCO/AACR Methods in Clinical Cancer Research Workshop
Blog
Mar 11, 2025, 01:20
Recordings of Past SeqSPACE Forums - NCI Division of Cancer Control and Population Sciences
Blog
Mar 10, 2025, 16:42
Miriam Mutebi: What it takes to succeed in medicine and surgery
Blog
Mar 10, 2025, 16:35
Karkinos Healthcare launched the Samvardhini: Towards a Cervical Cancer-Free Future
Blog
Mar 10, 2025, 16:27
Alique Topalian: Presented my posters at the Case Western Reserve University Cancer Disparities conference
Blog
Mar 10, 2025, 16:20
Runcie Chidebe: We need to replicate GF's work in Cervical Cancer to meet the 90/70/90 target
Blog
Mar 10, 2025, 16:13
Layth Mula-Hussain: Submit your abstract for the 4th MDOC Iraq series
Blog
Mar 10, 2025, 16:07
Leave a gift of cancer research in your Will - ICR
Blog
Mar 10, 2025, 16:02
Zero Childhood Cancer will receive a $112.6 million investment from the Australian Government - CCI
Blog
Mar 10, 2025, 15:53
Nelson Dusetti: Honored to be a Keynote Speaker at the 45th EORTC-PAMM Conference
Blog
Mar 10, 2025, 15:36
SPCC's Strategic Leading and Management in the Cancer Care Continuum course
Blog
Mar 10, 2025, 15:17
We are thrilled to welcome Dr. Jasmine Kamboj to the OncoDaily Editorial Board!